Remove 2025 Remove Biopharma Remove Collaboration
article thumbnail

Growth Perspectives: Key Highlights from DCAT 2024

Frost & Sullivan

Fuelling Growth: Strategic Investments, Acquisitions, and Expansions Samsung Biologics unveiled plans to expand capacity and geographic reach by initiating the construction of Bio Campus II with a $6 billion investment scheduled to begin operations in 2025 while completing its CGMP antibody-drug conjugate manufacturing facility within 2024.

article thumbnail

February 2025: Top 15 BioPharmaceutical Consultants, Professional Services, & Consulting Firms

Jake Jorgovan

Updated: February 2025 Biopharmaceutical consultants and consulting firms play a pivotal role in guiding companies through the intricate landscape of drug development, regulatory compliance, and market strategies. The Value of a Biopharma Consulting Firm Beyond mere compliance, these consultants offer strategic vision.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

February 2025: Top 12 Life Science Consultants & Consulting Firms

Jake Jorgovan

Updated: February 2025 "Science and everyday life cannot and should not be separated." - Rosalind Franklin It should go without saying, but life science can be quite complicated. Why work with Eradigm Consulting: Eradigm Consulting's approach is driven by a passion for high performance and delivering excellence in the biopharma industry.

article thumbnail

DCAT Week 2025: Key Takeaways & Industry Advancements

Frost & Sullivan

Held in New York during March 17-20, 2025, the event focused on pharmaceutical innovation, industry outlook, capacity expansion, and supply chain resilience, driven by the increasing digitization of drug development and manufacturing. trillion in 2024, is expected to grow at a 7% CAGR through 2030.

article thumbnail

Top 10 Strategic Imperatives Transforming the Life Sciences Industry in 2025

Frost & Sullivan

Download our full analysis on the top 10 strategic imperatives shaping life sciences in 2025. Growth Opportunities: Cloud-Native Multi-Lab Collaboration: SaaS facilitates seamless data sharing across multiple labs, improving diagnostic accuracy and operational efficiency. Want deeper insights? Want deeper insights?

article thumbnail

February 2025: Top 12 BioTechnology Recruiters, Headhunters, and Executive Search Firms

Jake Jorgovan

Updated: February 2025 In the intricate world of biotechnology, snagging the perfect talent feels like searching for a rare gene in a vast genome. They not only understand the technical qualifications required for a role but also appreciate the importance of soft skills and cultural fit in such a collaborative and fast-paced industry.

article thumbnail

JP Morgan Healthcare Conference 2025: Key Growth Opportunities Shaping the Future of Pharma and Biotechnology

Frost & Sullivan

The 43rd JP Morgan Healthcare Conference , held from January 1316, 2025, in San Francisco, brought together a vibrant ecosystem of global pharma stakeholders, innovative startups, emerging biotech companies, and investors. Key Examples : Johnson & Johnson announced the acquisition of Intra-Cellular Therapies, Inc.